NQF:  

The Steering Committee began meeting in January 2012 to evaluate the submissions and prepare the draft report.

• 0036: Use of Appropriate Medications for People with Asthma 
• 0047: Asthma: Pharmacologic Therapy for Persistent Asthma 
• 0091: COPD: Spirometry Evaluation   (Revised) 
• 0096: Empiric Antibiotic for Community-Acquired Bacterial Pneumonia  (Revised) 
• 0102: COPD: Inhaled Bronchodilator Therapy  (Revised) 
• 0102: COPD Medication Guide 
• 0143: CAC-1: Relievers for Inpatient Asthma 
• 0144: CAC-2 Systemic corticosteroids for Inpatient Asthma 
• 0147: Initial Antibiotic Selection for Community-Acquired Pneumonia (CAP) in Immunocompetent Patients 
• 0148: Blood Cultures Performed in the Emergency Department Prior to Initial Antibiotic Received in Hospital 
• 0179: Improvement in Dyspnea  
• 0231: Pneumonia Mortality Rate (IQI #20)  
• 0232: Vital Signs for Community-Acquired Bacterial Pneumonia 
• 0233: Assessment of Oxygen Saturation for Community-Acquired Bacterial Pneumonia (Revised) 
• 0334: PICU Severity-adjusted Length of Stay  
• 0335: PICU Unplanned Readmission Rate  
• 0336: Review of Unplanned PICU Readmissions   
• 0338: CAC-3: Home Management Plan of Care (HMPC) Document Given to Patient/Caregiver 
• 0341: PICU Pain Assessment on Admissions 
• 0342: PICU Periodic Pain Assessment 
• 0343: PICU Standardized Mortality Ratio 
• 0356: PN3a--Blood Cultures Performed Within 24 Hours Prior to or 24 Hours After Hospital Arrival for Patients Who Were Transferred or Admitted to the ICU Within 24 Hours of Hospital Arrival 
• 0468: Hospital 30-day, All-Cause, Risk-Standardized Mortality Rate (RSMR) Following Pneumonia Hospitalization  
• 0506: Hospital 30-day, All-Cause, Risk-Standardized Readmission Rate (RSRR) Following Pneumonia Hospitalization  
• 0513: Thorax CT: Use of Contrast Material  
• 0548: Suboptimal Asthma Control (SAC) and Absence of Controller Therapy (ACT) 
• 0549: Pharmacotherapy Management of COPD Exacerbation (PCE)  
• 0577: Use of Spirometry Testing in the Assessment and Diagnosis of COPD  
• 0620: Asthma - Short-Acting Beta Agonist Inhaler for Rescue Therapy 
• 1799: Medication Management for People with Asthma (MMA)  
• 1800: Asthma Medication Ratio (AMR) 
• 1825: COPD - Management of Poorly Controlled COPD 
• 1861: National Healthcare Safety Network (NHSN) Ventilator-Associated Event (VAE) Outcome Measure 
• 1876: Optimal Asthma Care  
• 1891: Hospital 30-Day, All-Cause, Risk-Standardized Readmission Rate (RSRR) following Chronic Obstructive Pulmonary Disease (COPD) Hospitalization  
• 1893: Hospital 30-Day, All-Cause, Risk-Standardized Mortality Rate (RSMR) following Chronic Obstructive Pulmonary Disease (COPD) Hospitalization  
• 1895: Assessment of Mental Status for Community-Acquired Bacterial Pneumonia (Revised) 
  
   
• Workgroup Briefing Memo (PDF)
• Pulmonary Report (PDF)
• Critical Care Measure Gap Report (PDF)